The Global Cell Therapy Market was valued at US$ 7.7 Bn in 2020, and it is expected to reach US$

19.5 Bn by 2027, with a CAGR of 14.2%, during the forecast period, 2021 - 2027.

The increasing prevalence of cancer during the forecast period is the major propelling factor for the

growth of the target market. Additionally, government is taking initiative and investing in the R&D

activities which is the driving factor for the growth of the global cell therapy market. Moreover, the

number of cell bank is rising and the positively support of governments for the stem cell banking is the

boosting factor for the growth of cell therapy market.

In addition to this, cell therapy uses to diagnose the cancer and used for the treatment of the cancer

fuels the target market growth. According to World Health Organization (WHO), in the year 2020,

around 2.3 million women were diagnosed with breast cancer. In addition, according to the data

published by NHS hospital UK, around 131,640 admitted in 2018-19, which were for primary diagnosis

of cancer. Also, this number is increased from 122,073 in 2017-18. Besides this, the increased in

number of obese populace due to unhealthy lifestyle which is another uplifting factor for the growth of

cell therapy market.

Request a Sample Report- https://www.alltheresearch.com/sample-request/504

However, the less skilled professional in the emerging economies is anticipated to hamper the market

growth. The developing and underdeveloped countries lack the infrastructure required for stem cells

banking, and the people in these countries are not aware about the merits and demerits of cell therapy.

This hampers their decision-making ability when it comes to cell therapy market analysis. Furthermore,

availability of cell therapy centres in the various areas is a challenge for the growth of the target market.

Global Cell Therapy Market by Region Outlook (Revenue, USD Million, 2021-2027)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

In terms of geography, the Asia Pacific region is the fastest growing region for cell therapy market. The

region is witnessing huge growing adoption of cell therapy due to increasing chronic diseases in the aged

and obese population. The governments across the Asia Pacific region is making significant investments

to improve the stem cells banking. Additionally, improving healthcare facilities are some other factors

supporting in the Asia-Pacific regional market.

The Global Cell Therapy Market Segmentation

Global Cell Therapy Market by Cell Type Outlook (Revenue, USD Million, 2021-2027)

Stem Cell

Bone Marrow

Blood

Umbilical Cord-Derived

Adipose-Derived Stem Cell

Others

Non-stem Cell

Global Cell Therapy Market by Therapeutic Area Outlook (Revenue, USD Million, 2021-2027)

Malignancies

Musculoskeletal Disorders

Autoimmune Disorders

Dermatology

Other Therapies

Global Cell Therapy Market by Therapy Type Outlook (Revenue, USD Million, 2021-2027)

Autologous

Allogeneic

Cell Therapy Market Key Findings:

Based on the cell type, the stem cells segment accounted for the largest share of the market in

2020.

Based on therapeutic area, the malignancies segment accounted for the largest share in the cell

therapy market.

Based on regions, the North America region held a maximum market share of more than 25.0%

in the year 2020 in the cell therapy market.

Cell Therapy Market Company Profiles and Competitive Intelligence

The key players operating in the Cell Therapy Market are:

Osiris Therapeutics, Inc.

NuVasive, Inc.

JCR Pharmaceuticals Co. Ltd.

Kolon Tissue Gene, Inc.

Stemedica Cell Technologies, Inc.

Mesoblast Ltd.

Cells for cells

Holostem Terapie Avanzate S.r.l.

Medipost Co., Ltd.

Takeda Pharmaceutical Company

RTI Surgical

AlloSource

CORESTEM

Smith & Nephew

Regrow Biosciences

Stempeutics Research

Cell Therapy Market Recent News:

In June 2021, in India, for the first time, IIT Bombay, worked together with Tata Memorial

Hospital for the cell therapy called as CAR-T.

In September 2019, Google banned advertisement which are not proven therapies of cell

therapy which includes stem cell therapy.

Read More- https://www.alltheresearch.com/report/504/cell-therapy-market